Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...

Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated ...

These rashes can vary from mild to severe and may appear as red spots, hives, or peeling skin. Common drugs that cause such ...

Scarring is a natural part of the healing process after an injury. Its appearance and its treatment depend on multiple factors. The depth and size of the wound or cut and the location of the ...

Like all prescription products, it should be given under a doctor's care. While it is effective, if treatment is discontinued, results may not be maintained. Permanent hair loss can also be ...

Both the overall response rate (ORR) and the disease control rate (DCR) were also higher in patients treated with ivonescimab than those treated with Keytruda. Treatment with the drug achieved an ...

There are a number of treatment options for ED. Initially, a provider may advise the patient to take steps to improve their lifestyle habits, such as increasing their level of physical activity ...

Head lice live in all types of hair, whether it’s curly, straight, dyed or natural. Before you start treatment, understand how your child could have gotten head lice. Head lice don’t jump, they don’t ...

The trial evaluated monotherapy ivonescimab against monotherapy Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in patients with locally advanced or metastatic non-small cell lung cancer ...

On Sunday, a small biotech company called Summit Therapeutics won a remarkable victory, saying its experimental drug outperformed Merck’s Keytruda, the world’s best-selling drug, in non-small ...